Filtros : "Pharmaceutical Development and Technology" "FÁRMACOS" Removido: "2018" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutical Development and Technology. Unidade: FCF

    Subjects: NANOPARTÍCULAS, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA, Sávio Fujita et al. Physical chemical properties of furosemide nanocrystals developed using rotation revolution mixer. Pharmaceutical Development and Technology, 2015Tradução . . Disponível em: https://doi.org/10.3109/10837450.2015.1063650. Acesso em: 28 nov. 2025.
    • APA

      Barbosa, S. F., Takatsuka, T., Tavares, G. D., Araujo, G. L. B. de, Wang, H., Vehring, R., et al. (2015). Physical chemical properties of furosemide nanocrystals developed using rotation revolution mixer. Pharmaceutical Development and Technology. doi:10.3109/10837450.2015.1063650
    • NLM

      Barbosa SF, Takatsuka T, Tavares GD, Araujo GLB de, Wang H, Vehring R, Löbenberg R, Bou-Chacra NA. Physical chemical properties of furosemide nanocrystals developed using rotation revolution mixer [Internet]. Pharmaceutical Development and Technology. 2015 ;[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2015.1063650
    • Vancouver

      Barbosa SF, Takatsuka T, Tavares GD, Araujo GLB de, Wang H, Vehring R, Löbenberg R, Bou-Chacra NA. Physical chemical properties of furosemide nanocrystals developed using rotation revolution mixer [Internet]. Pharmaceutical Development and Technology. 2015 ;[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2015.1063650
  • Source: Pharmaceutical Development and Technology. Unidades: EP, FCF

    Subjects: COMPRIMIDOS, CELULOSE, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 28 nov. 2025.
    • APA

      Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508
    • NLM

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2012.693508
    • Vancouver

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2012.693508

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025